Author

Alessandro Plebani

Universit

Biography

Alessandro Plebani from Medico presso University of Brescia, Brescia Area, Italy. His research interests include Clinical Immunology, Pediatrics, Rheumatology, Molecular immunology, Adaptive immunology, Molecular therapeutics.He is currently working as a Professor in the Department of Medicine. His research interests includes Medicine. He is serving as an editorial member and reviewer of several international reputed journals. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Coronavirus disease 2019 in patients with inborn errors of immunity: an international study
I Meyts, G Bucciol, I Quinti, B Neven, A Fischer, E Seoane, ...Journal of Allergy and Clinical Immunology 147 (2), 520-531, 2021202
298
2021
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations
T Lorenzini, M Fliegauf, N Klammer, N Frede, M Proietti, A Bulashevska, ...Journal of Allergy and Clinical Immunology 146 (4), 901-911, 2020202
73
2020
Epidemiology, clinical features and prognostic factors of pediatric SARS-CoV-2 infection: results from an Italian multicenter study
S Garazzino, A Lo Vecchio, L Pierantoni, FI Calò Carducci, F Marchetti, ...Frontiers in pediatrics 9, 6493, 2021202
58
2021
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity
C Milito, V Lougaris, G Giardino, A Punziano, A Vultaggio, M Carrabba, ...The Journal of Allergy and Clinical Immunology: In Practice 9 (7), 2904-2906. e2, 2021202
56
2021
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations
J Thalhammer, G Kindle, A Nieters, S Rusch, MRJ Seppänen, A Fischer, ...Journal of Allergy and Clinical Immunology 148 (5), 1332-1341. e5, 2021202
55
2021
Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper‐IgM syndrome
V Vavassori, E Mercuri, GE Marcovecchio, MC Castiello, G Schiroli, ...EMBO Molecular Medicine 13 (3), e13545, 2021202
27
2021
Factors associated with severe gastrointestinal diagnoses in children with SARS-CoV-2 infection or multisystem inflammatory syndrome
AL Vecchio, S Garazzino, A Smarrazzo, E Venturini, M Poeta, P Berlese, ...JAMA network open 4 (12), e2139974-e2139974, 2021202
26
2021
RAC2 and primary human immune deficiencies
V Lougaris, M Baronio, L Gazzurelli, A Benvenuto, A PlebaniJournal of Leucocyte Biology 108 (2), 687-696, 2020202
24
2020
Non-specific oral and cutaneous manifestations of Coronavirus Disease 2019 in children
E Bardellini, MP Bondioni, F Amadori, F Veneri, V Lougaris, A Meini, ...Medicina Oral, Patología Oral y Cirugía Bucal 26 (5), e549, 2021202
23
2021
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome
VK Rao, S Webster, A Šedivá, A Plebani, C Schuetz, A Shcherbina, ...Blood, The Journal of the American Society of Hematology 141 (9), 971-983, 202
23
2023
Activated phosphoinositide 3-kinase delta syndrome 1: clinical and immunological data from an Italian cohort of patients
G Tessarin, S Rossi, M Baronio, L Gazzurelli, M Colpani, A Benvenuto, ...Journal of Clinical Medicine 9 (10), 3335, 2020202
18
2020
The impact of SARS-CoV-2 infection in patients with inborn errors of immunity: the experience of the Italian primary immunodeficiencies network (IPINet)
G Giardino, C Milito, V Lougaris, A Punziano, M Carrabba, F Cinetto, ...Journal of Clinical Immunology 42 (5), 935-946, 2022202
18
2022
Granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID): a multicenter retrospective study of patients from Italian PID referral …
F Cinetto, R Scarpa, M Carrabba, D Firinu, V Lougaris, H Buso, G Garzi, ...Frontiers in Immunology 12, 627423, 2021202
16
2021
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations
F Saettini, G Fazio, P Corti, M Quadri, C Bugarin, G Gaipa, F Penco, ...Clinical Immunology 218, 108525, 2020202
16
2020
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children
A Plebani, A Meini, M Cattalini, V Lougaris, A Bugatti, F Caccuri, A CarusoClinical Immunology (Orlando, Fla.) 221, 108613, 2020202
15
2020
The Italian registry for primary immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): twenty years of experience (1999–2019)
V Lougaris, A Pession, M Baronio, A Soresina, R Rondelli, L Gazzurelli, ...Journal of Clinical Immunology 40, 1026-1037, 2020202
15
2020
Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents
R Lévy, D Langlais, V Béziat, F Rapaport, G Rao, T Lazarov, M Bourgey, ...The Journal of Clinical Investigation 131 (17), 2021202
14
2021
Known and potential molecules associated with altered B cell development leading to predominantly antibody deficiencies
P Amirifar, R Yazdani, G Azizi, MR Ranjouri, A Durandy, A Plebani, ...Pediatric Allergy and Immunology 32 (8), 1601-1615, 2021202
10
2021
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity
E Cirillo, G Giardino, S Ricci, V Moschese, V Lougaris, F Conti, C Azzari, ...Journal of Allergy and Clinical Immunology 146 (5), 967-93, 2020202
8
2020
Simple measurement of IgA predicts immunity and mortality in ataxia-telangiectasia
S Zielen, RP Duecker, S Woelke, H Donath, S Bakhtiar, A Buecker, ...Journal of Clinical Immunology 41, 1878-1892, 2021202
6
2021